No abstract available
MeSH terms
-
Aged
-
Androstadienes / administration & dosage
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / pharmacology*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / pharmacology*
-
Biomarkers / blood
-
Biomarkers, Tumor / blood
-
Breast Neoplasms / complications
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Drug Combinations
-
ErbB Receptors / drug effects
-
ErbB Receptors / metabolism
-
Female
-
Hepacivirus / drug effects*
-
Hepacivirus / isolation & purification
-
Hepatitis C, Chronic / blood
-
Hepatitis C, Chronic / complications
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Neoplasm Staging
-
Oxonic Acid / administration & dosage
-
Receptor, ErbB-2 / blood
-
Receptors, Estrogen / blood
-
Tegafur / administration & dosage
-
Trastuzumab
Substances
-
Androstadienes
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Antiviral Agents
-
Biomarkers
-
Biomarkers, Tumor
-
Drug Combinations
-
Receptors, Estrogen
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
ERBB2 protein, human
-
ErbB Receptors
-
Receptor, ErbB-2
-
exemestane
-
Trastuzumab